USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Assignments on the Web > Patent Query

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:	048270/0813			Pages:	23
		Recorded:	02/07/2019
Conveyance:	SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).

Total properties: 32

Patent #:	7829084	Issue Dt:	11/09/2010	Application #:	10627556	Filing Dt:	07/26/2003
Publication #:	US20050136049	Pub Dt:	06/23/2005
Title:	BINDING CONSTRUCTS AND METHODS FOR USE THEREOF

Patent #:	8106161	Issue Dt:	01/31/2012	Application #:	11088693	Filing Dt:	03/23/2005
Publication #:	US20050202028	Pub Dt:	09/15/2005
Title:	BINDING DOMAIN-IMMUNOGLOBULIN FUSION PROTEINS

Patent #:	10307481	Issue Dt:	06/04/2019	Application #:	11493132	Filing Dt:	07/25/2006
Publication #:	US20070059306	Pub Dt:	03/15/2007
Title:	CD37 IMMUNOTHERAPEUTICS AND USES THEREOF

Patent #:	7846434	Issue Dt:	12/07/2010	Application #:	12082497	Filing Dt:	04/11/2008
Publication #:	US20090041765	Pub Dt:	02/12/2009
Title:	MATERIALS AND METHODS FOR IMPROVED IMMUNOGLYCOPROTEINS

Patent #:	8409577	Issue Dt:	04/02/2013	Application #:	12304562	Filing Dt:	07/22/2010
Publication #:	US20120034245	Pub Dt:	02/09/2012
Title:	SINGLE-CHAIN MULTIVALENT BINDING PROTEINS WITH EFFECTOR FUNCTION

Patent #:	9101609	Issue Dt:	08/11/2015	Application #:	12422780	Filing Dt:	04/13/2009
Publication #:	US20090274692	Pub Dt:	11/05/2009
Title:	CD37 IMMUNOTHERAPEUTIC AND COMBINATION WITH BIFUNCTIONAL CHEMOTHERAPEUTIC THEREOF

Patent #:	8147835	Issue Dt:	04/03/2012	Application #:	12541062	Filing Dt:	08/13/2009
Publication #:	US20100034820	Pub Dt:	02/11/2010
Title:	BINDING DOMAIN-IMMUNOGLOBULIN FUSION PROTEINS

Patent #:	8333966	Issue Dt:	12/18/2012	Application #:	12678857	Filing Dt:	07/15/2010
Publication #:	US20110171208	Pub Dt:	07/14/2011
Title:	CD37 IMMUNOTHERAPEUTICS AND USES THEREOF

Patent #:	8188237	Issue Dt:	05/29/2012	Application #:	12901295	Filing Dt:	10/08/2010
Publication #:	US20110105729	Pub Dt:	05/05/2011
Title:	BINDING DOMAIN-IMMUNOGLOBULIN FUSION PROTEINS

Patent #:	8197810	Issue Dt:	06/12/2012	Application #:	12901297	Filing Dt:	10/08/2010
Publication #:	US20110091461	Pub Dt:	04/21/2011
Title:	BINDING DOMAIN-IMMUNOGLOBULIN FUSION PROTEINS

Patent #:	8383106	Issue Dt:	02/26/2013	Application #:	12909769	Filing Dt:	10/21/2010
Publication #:	US20110256125	Pub Dt:	10/20/2011
Title:	MATERIALS AND METHODS FOR IMPROVED IMMUNOGLYCOPROTEINS

Patent #:	9493564	Issue Dt:	11/15/2016	Application #:	13122383	Filing Dt:	05/19/2011
Publication #:	US20120100139	Pub Dt:	04/26/2012
Title:	CD86 Antagonist Multi-Target Binding Proteins

Patent #:	8853366	Issue Dt:	10/07/2014	Application #:	13396147	Filing Dt:	02/14/2012
Publication #:	US20120213773	Pub Dt:	08/23/2012
Title:	BINDING DOMAIN-IMMUNOGLOBULIN FUSION PROTEINS

Patent #:	9005612	Issue Dt:	04/14/2015	Application #:	13451641	Filing Dt:	04/20/2012
Publication #:	US20130142793	Pub Dt:	06/06/2013
Title:	BINDING DOMAIN-IMMUNOGLOBULIN FUSION PROTEINS

Patent #:	10143748	Issue Dt:	12/04/2018	Application #:	13836103	Filing Dt:	03/15/2013
Publication #:	US20140004117	Pub Dt:	01/02/2014
Title:	B-CELL REDUCTION USING CD37-SPECIFIC AND CD20-SPECIFIC BINDING MOLECULES

Patent #:	10202452	Issue Dt:	02/12/2019	Application #:	14395689	Filing Dt:	10/20/2014
Publication #:	US20150232557	Pub Dt:	08/20/2015
Title:	CD3 BINDING POLYPEPTIDES

Patent #:	9587008	Issue Dt:	03/07/2017	Application #:	14475881	Filing Dt:	09/03/2014
Publication #:	US20140369994	Pub Dt:	12/18/2014
Title:	METHOD OF PRODUCING RECOMBINANT VITAMIN K DEPENDENT PROTEINS

Patent #:	NONE	Issue Dt:		Application #:	14860042	Filing Dt:	09/21/2015
Publication #:	US20160244738	Pub Dt:	08/25/2016
Title:	RECOMBINANT VITAMIN K DEPENDENT PROTEINS WITH HIGH SIALIC ACID CONTENT AND METHODS OF PREPARING SAME

Patent #:	NONE	Issue Dt:		Application #:	15040744	Filing Dt:	02/10/2016
Publication #:	US20170008960	Pub Dt:	01/12/2017
Title:	TCR Complex Immunotherapeutics

Patent #:	NONE	Issue Dt:		Application #:	15126922	Filing Dt:	09/16/2016
Publication #:	US20170089885	Pub Dt:	03/30/2017
Title:	CELL LINE-BASED REDIRECTED T-CELL CYTOTOXICITY ASSAY

Patent #:	NONE	Issue Dt:		Application #:	15281441	Filing Dt:	09/30/2016
Publication #:	US20170015747	Pub Dt:	01/19/2017
Title:	CD86 ANTAGONIST MULTI-TARGET BINDING PROTEINS

Patent #:	NONE	Issue Dt:		Application #:	15550143	Filing Dt:	08/10/2017
Publication #:	US20180022819	Pub Dt:	01/25/2018
Title:	COMPOSITIONS AND METHODS FOR COMBINATION THERAPY WITH PROSTATE-SPECIFIC MEMBRANE ANTIGEN BINDING PROTEINS

Patent #:	9782478	Issue Dt:	10/10/2017	Application #:	15585921	Filing Dt:	05/03/2017
Publication #:	US20170306045	Pub Dt:	10/26/2017
Title:	PROSTATE-SPECIFIC MEMBRANE ANTIGEN BINDING PROTEINS AND RELATED COMPOSITIONS AND METHODS

Patent #:	NONE	Issue Dt:		Application #:	15617833	Filing Dt:	06/08/2017
Publication #:	US20180118823	Pub Dt:	05/03/2018
Title:	SINGLE-CHAIN MULTIVALENT BINDING PROTEINS WITH EFFECTOR FUNCTION

Patent #:	NONE	Issue Dt:		Application #:	15699474	Filing Dt:	09/08/2017
Publication #:	US20180100021	Pub Dt:	04/12/2018
Title:	PROSTATE-SPECIFIC MEMBRANE ANTIGEN BINDING PROTEINS AND RELATED COMPOSITIONS AND METHODS

Patent #:	11352426	Issue Dt:	06/07/2022	Application #:	15761499	Filing Dt:	03/20/2018
Publication #:	US20180273622	Pub Dt:	09/27/2018
Title:	CD3 BINDING POLYPEPTIDES

Patent #:	NONE	Issue Dt:		Application #:	15802636	Filing Dt:	11/03/2017
Publication #:	US20180273642	Pub Dt:	09/27/2018
Title:	HETERODIMER BINDING PROTEINS AND USES THEREOF

Patent #:	NONE	Issue Dt:		Application #:	15875373	Filing Dt:	01/19/2018
Publication #:	US20190032101	Pub Dt:	01/31/2019
Title:	METHOD OF PRODUCING BIOLOGICALLY ACTIVE VITAMIN K DEPENDENT PROTEINS BY RECOMBINANT METHODS

Patent #:	10676533	Issue Dt:	06/09/2020	Application #:	15933324	Filing Dt:	03/22/2018
Publication #:	US20190071513	Pub Dt:	03/07/2019
Title:	Methods of treatment of CD123 overexpressing disorders

Patent #:	NONE	Issue Dt:		Application #:	16028736	Filing Dt:	07/06/2018
Publication #:	US20190167797	Pub Dt:	06/06/2019
Title:	STABILIZED FACTOR IX FORMULATIONS CONTAINING TREHALOSE

Patent #:	10239949	Issue Dt:	03/26/2019	Application #:	16041309	Filing Dt:	07/20/2018
Publication #:	US20190016816	Pub Dt:	01/17/2019
Title:	ONCOFETAL ANTIGEN BINDING PROTEINS AND RELATED COMPOSITIONS AND METHODS

Patent #:	NONE	Issue Dt:		Application #:	16172096	Filing Dt:	10/26/2018
Publication #:	US20190290755	Pub Dt:	09/26/2019
Title:	B-CELL REDUCTION USING CD37-SPECIFIC AND CD20-SPECIFIC BINDING MOLECULES

Assignors

APTEVO THERAPEUTICS INC.

Exec Dt:

02/07/2019

APTEVO BIOTHERAPEUTICS INC.

Exec Dt:

02/07/2019

APTEVO RESEARCH AND DEVELOPMENT LLC

Exec Dt:

02/07/2019

Assignee

MIDCAP FINANCIAL TRUST, AS AGENT

7255 WOODMONT AVENUE, SUITE 200

BETHESDA, MARYLAND 20814

Correspondence name and address
	VALERIE BRENNAN, HOGAN LOVELLS US LLP
	ATTN: BOX INTELLECTUAL PROPERTY
	7930 JONES BRANCH DRIVE, 9TH FLOOR
	MCLEAN, VA 22102

Search Results as of: 05/23/2024 07:16 AM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6